See also this year's filing and all EDGAR filings for this company.
PDF Report 0001281895_2017_Rocket_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 6.511504189386886, 'aggregate_val': 56479000, 'exp_sum': 7519000, 'exp_to_value': {'LiabilitiesCurrent': 7212000, 'LiabilitiesNoncurrent': 307000, 'remainder_Liabilities': 0}} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 11.075564498099709, 'aggregate_val': 54014000, 'exp_sum': 4473000, 'exp_to_value': {'LiabilitiesCurrent': 4070000, 'LiabilitiesNoncurrent': 403000, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0001281895, Rocket Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 128,349,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,130,000 |
| 3 | remainder_Assets | 168,000 |
| 4 | LiabilitiesCurrent | 7,212,000 |
| 5 | LiabilitiesNoncurrent | 307,000 |
| 6 | remainder_Liabilities | 48,960,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 1,418,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -41,436,000 |
| 13 | remainder_ComprehensiveNetIncome | -43,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 129,647,000 |
| 1 | Liabilities | 56,479,000 |
| 2 | Expenses | 1,418,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 73,168,000 |
| 5 | NetIncome | -42,854,000 |
| 6 | ComprehensiveNetIncome | -42,875,500 |
| 7 | BaseVar | 114,511,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.25 |
| 9 | EconomicCapitalRatio | 2.50 |
Edgar->Model Mapping
Feature Distribution
Change over Time
